Definition
Human immunodeficiency virus type 2 (HIV-2) is a retrovirus of the Lentivirus genus that may cause AIDS. However, the pace of disease development during an HIV-2 infection is much slower as compared with the course of an HIV-1 infection. In fact, many HIV-2-infected individuals may never develop AIDS. Several parameters influence the rate of HIV disease progression, and heightened level of chronic immune activation is one such factor. Chronic immune activation can be depicted by a wide range of dysregulated immunological responses, including increased frequencies of activated, but virus-unspecific, immune cells. Elevated levels of circulating cytokines, inflammation markers, and microbial products are also traits of chronic immune activation during an HIV infection.
HIV-2 Infection, a Long-Term Nonprogressive Lentiviral Disease
The human immunodeficiency virus type 2 (HIV-2) is a Lentivirus with distinct pathogenesis, despite its close relationship to HIV-1 (Table 1) (de...
References
Bosinger SE, Sodora DL, Silvestri G. Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS. 2011;6(5):411–8.
Cavaleiro R, Brunn GJ, Albuquerque AS, Victorino RM, Platt JL, Sousa AE. Monocyte-mediated T cell suppression by HIV-2 envelope proteins. Eur J Immunol. 2007;37(12):3435–44.
Cavaleiro R, Baptista AP, Soares RS, Tendeiro R, Foxall RB, Gomes P, et al. Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. PLoS Pathog. 2009;5(11):e1000667.
de Silva TI, Cotten M, Rowland-Jones SL. HIV-2: the forgotten AIDS virus. Trends Microbiol. 2008;16(12):588–95.
Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med. 2009;60:471–84.
Duvall MG, Lore K, Blaak H, Ambrozak DA, Adams WC, Santos K, et al. Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol. 2007;81(24):13486–98.
Feldmann J, Leligdowicz A, Jaye A, Dong T, Whittle H, Rowland-Jones SL. Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression. J Virol. 2009;83(24):12968–72.
Jaffar S, Van der Loeff MS, Eugen-Olsen J, Vincent T, Sarje-Njie R, Ngom P, et al. Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. AIDS Res Hum Retroviruses. 2005;21(6):560–4.
Khalid M, Yu H, Sauter D, Usmani SM, Schmokel J, Feldman J, et al. Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection. J Virol. 2012;86(9):4906–20.
Laguette N, Benkirane M. How SAMHD1 changes our view of viral restriction. Trends Immunol. 2012;33(1):26–33.
Leligdowicz A, Feldmann J, Jaye A, Cotten M, Dong T, McMichael A, et al. Direct relationship between virus load and systemic immune activation in HIV-2 infection. J Infect Dis. 2010a;201(1):114–22.
Leligdowicz A, Onyango C, Yindom LM, Peng Y, Cotten M, Jaye A, et al. Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection. Eur J Immunol. 2010b;40(7):1963–72.
Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, et al. Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cytokine. 2009;46(3):325–31.
Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis. 2010;201(8):1150–4.
Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, Kiwanuka N, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A. 2009;106(16):6718–23.
Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell. 2006;125(6):1055–67.
Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol. 2002;169(6):3400–6.
Tendeiro R, Foxall RB, Baptista AP, Pinto F, Soares RS, Cavaleiro R, et al. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia. AIDS. 2012;26(9):1065–71.
Whittle H, Egboga A, Todd J, Morgan G, Rolfe M, Sabally S, et al. Immunological responses of Gambians in relation to clinical stage of HIV-2 disease. Clin Exp Immunol. 1993;93(1):45–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Nowroozalizadeh, S., Jansson, M. (2013). HIV-2 Infection: The Role of Immune Activation in Pathogenesis. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_46-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_46-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine